Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
17.21
-0.76 (-4.23%)
At close: Mar 20, 2026, 4:00 PM EDT
17.52
+0.31 (1.78%)
After-hours: Mar 20, 2026, 7:54 PM EDT
Apellis Pharmaceuticals (APLS) Product Revenue by Segment
History
| Date | Syfovre | Empaveli |
|---|---|---|
| Dec 31, 2025 | 587.00M | 102.00M |
| Sep 30, 2025 | 599.55M | 90.69M |
| Jun 30, 2025 | 600.59M | 88.47M |
| Mar 31, 2025 | 604.58M | 92.22M |
| Dec 31, 2024 | 611.85M | 98.13M |
| Sep 30, 2024 | 558.35M | 99.13M |
| Jun 30, 2024 | 481.67M | 98.42M |
| Mar 31, 2024 | 394.39M | 96.21M |
| Dec 31, 2023 | 275.28M | 91.04M |
| Sep 30, 2023 | 160.98M | 86.34M |
| Jun 30, 2023 | 85.70M | 80.14M |
| Mar 31, 2023 | 18.36M | 73.49M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.